• You are here:  
  • Home
  • Publications

Publications

Α.1 Publications in international journals

  1. The effect of intrathecal fentanyl added to lidocaine for open prostatectomy surgery. European Journal of Anaesthesiology, Volume 22, Supplement 34, 2005.
  2. Brachytherapy for the treatment of prostate cancer. Cancer J., 13(5):302-312, September/October, 2007.
  3. Biopsy and implantation of the seminal vesicles. Brachytherapy. Vol. 11 (5): 334-340, September 2012.

Α.2 Publications in Greek journals

  1. Management of major bleeding in operating female urethral prolapse. Hellenic Urology, volume 14, issue 3. July-September 2002.
  2. Leiomyoma of female urethra. Hellenic Urology, volume 14, issue 3. July-September 2002.
  3. Evaluation of Bosniak classification for differential diagnosis of renal cystic masses. Hellenic Urology, volume 14, issue 3. July-September 2002.
  4. Brachytherapy for prostate cancer – The latest news. Contemporary Urology. April-June 2012/32.
  5. Brachytherapy for prostate adenocarcinoma. Iatrika Analekta. Volume C’, Issue 16. October-December 2012, p. 754-758.

B. Book chapters

  1. «Prostate Specific Antigen.» Brachytherapy of Localized Prostate Carcinoma. ISBN 978-960-394-547-5. 2009.
  2. «Dosimetry Protocol. Imlantation-Radiation Precautions.» Brachytherapy of Localized Prostate Carcinoma. ISBN 978-960-394-547-5. 2009.
  3. «Combination of Brachytherapy-Hormonal Therapy» Brachytherapy of Localized Prostate Carcinoma. ISBN 978-960-394-547-5. 2009.

C.1 Abstracts in international congresses

  1. Elimination of t-PSA and f-PSA after radical retropubic prostatectomy. XIXth EAU Congress. 24-27 March 2004. Vienna, Austria.
  2. Treatment of locally advanced prostate cancer with combination of hormonal therapy, I-125 brachytherapy boost and conformal external beam irradiation: preliminary results. XXth EAU Congress. 16-19 March 2005. CNR, Istanbul, Turkey.
  3. The effect of intrathecal fentanyl added to lidocaine for open prostatectomy surgery. Annual Meeting of the European Society of Anaesthesiology. 28-31 May 2005. Vienna, Austria.
  4. Dose response study of Pd-103 prostate seed implantation. ASTRO 49th Annual Meeting. October 28-November 1, 2007. Los Angeles Convention Center. Los Angeles, California, USA.
  5. Impact of prostate volume as a predictor of urinary incontinence following radioactive seed implantation for prostate cancer. ASTRO 49th Annual Meeting. October 28-November 1, 2007. Los Angeles Convention Center. Los Angeles, California, USA.
  6. Treatment of T3b prostate cancer with a combination of hormonal therapy, permanent brachytherapy and external beam irradiation. 2008 World Congress of Brachytherapy. Joint Brachytherapy Meeting: ABS, GEC/ESTRO, ALATRO, CBG-CARO, JASTRO, ABG and AROI-IBS. May 4-6, 2008. Marriot Copley Place. Boston, MA, USA.
  7. Defining the risk of developing grade 2 proctitis following combined modality therapy using a rectal dose-volume histogram analysis and biologic equivalent dose. ASTRO 50th Annual Meeting. September 21-25, 2008. Boston Convention and Exhibition Center. Boston, MA, USA.
  8. Transperineal template-guided mapping biopsy for detection of prostate cancer as an initial approach. 10th Congress of the European Federation of Internal Medicine. October 5-8 2011, Hilton Hotel, Athens, Greece.
  9. Outcomes of transperineal template-guided mapping prostate biopsy after negative transrectal ultrasound guided biopsy. 3rd Congress of the Mediterranean Multidisciplinary Oncology Forum. October 24-26, 2013. Divani Caravel Hotel. Athens, Greece.
  10.  Treatment of locally advanced (high risk) prostate cancer (PCa) by a combination of hormonal therapy, brachytherapy and external beam irradiation. 3rd Congress of the Mediterranean Multidisciplinary Oncology Forum. October 24-26, 2013. Divani Caravel Hotel. Athens, Greece.
  11. Transperineal saturation prostate biopsy (TSPB): Factors predicting oncologic and quality of life outcomes. 19th Annual Scottsdale Prostate Cancer Symposium 2014. February 27-March 2, 2014. A JW Marriot Camelback Inn Resort and Spa. Scottsdale, Arizona, USA.
  12. Testosterone recovery (TR) and PSA increase following neoadjuvant hormone therapy (NHT) with prostate irradiation. 19th Annual Scottsdale Prostate Cancer Symposium 2014. February 27-March 2, 2014. A JW Marriot Camelback Inn Resort and Spa. Scottsdale, Arizona, USA.

C.2 Abstracts in Greek Congresses

    1. Hormonal fluctuations in patients with prostate cancer after radical prostatectomy. 16th Greek Urological Congress. September 25-29, 2002. Kalamata, Greece.
    2. Management of stress urinary incontinence with tension free vaginal tape (TVT). 15/05/02. 16th Greek Urological Congress. September 25-29, 2002. Kalamata, Greece.
    3. Prognostic importance of DNA nucleus ploidy in surgically removed prostate tumor specimens. 16th Greek Urological Congress. September 25-29, 2002. Kalamata, Greece.
    4. Usefulness of transitional zone biopsy in detecting prostate adenocarcinoma. 16th Greek Urological Congress. September 25-29, 2002. Kalamata, Greece.
    5. Anuria from echinococcous cyst in patient with one kidney. 16th Greek Urological Congress. September 25-29, 2002. Kalamata, Greece.
    6. Brachytherapy on confined prostate carcinoma. Our five years experience. 1st International Greek Biotechnology Forum. June 10-12, 2004. National Research Institute. Athens, Greece.
    7. Prostate brachytherapy at Hygeia hospital. Radiation Oncology: Redefining the future… today!, May 16-17, 2009. Hilton Hotel, Athens, Greece.
    8. Prostate brachytherapy at Hygeia Hospital. Results with a median follow up of 4 years. “1st Panhellenic Congress of oncologic imaging” October 23-25, 2009. Megaro International Congress Center, Athens, Greece.
    9. 3-D Transperineal prostate biopsy (mapping biopsy). Our initial Experience at Hygeia Hospital. «1st Panhellenic Congress of oncologic imaging» October 23-25, 2009. Megaro International Congress Center, Athens, Greece.
    10. 3-D Transperineal prostate biopsy (mapping biopsy). Our Experience at Hygeia Hospital. 20th Panhellenic Urological Congress, October 24-27, 2010. Grand Resort Hotel, Limassol, Cyprus.
    11. Interstitial radioactive I-125 seeds implantation of prostate with Real-Time technique. Results with a median follow up of 4 years. 20th Panhellenic Urological Congress, October 24-27, 2010. Grand Resort Hotel, Limassol, Cyprus.
    12. Transperineal template-guided mapping biopsy for detection of prostate cancer as an initial approach. 17th Panhellenic Congress of Internal Medicine, October 5-8, 2011. Hilton Hotel, Athens, Greece.
    13. Transperineal template-guided prostate biopsy for detection of transitional zone involvement in prostate cancer . “2nd Panhellenic Congress of oncologic imaging”, December 9-11, 2011. Royal Olympic Hotel, Athens, Greece.
    14. Combination of hormonal therapy, brachytherapy and supplemental external beam irradiation in patients with gleason score 7-10 prostate cancer. “2nd Panhellenic Congress of oncologic imaging”, December 9-11, 2011. Royal Olympic Hotel, Athens, Greece.
    15. Treatment of Gleason 8-10 prostate cancer with a triple offensive combination regimen. 21th Panhellenic Congress of Urology. October 11-14, 2012. Hilton Hotel, Athens, Greece.
    16. Morbidity of transperineal prostate biopsy in diagnosis and staging of prostate cancer. 21th Panhellenic Congress of Urology. October 11-14, 2012. Hilton Hotel, Athens, Greece.
    17. Prostate cancer. Transperineal prostate biopsy. Blood-free treatment. Brachytherapy. AKOS-Prolipsis Erga. October 21, 2012. Holy Metamorfoseos Monastery. Nafpaktos, Greece.
    18. «AKOS-Blood-less wins». Participation in round-table: «Prostate Cancer» November 11, 2012. Athinais, Polyhoros Politismou. Athens, Greece.

    19. Comparison of compression elastography findings and pathology results through transperineal template guided prostate biopsy. 3nd Panhellenic Oncological-Imaging Congress. December 13-15, 2013. Mitera Hospital, Congress Center “N. Louros”, Maroussi, Athens, Greece. (HONORED-GOLD MEDAL)

    20. Disease free survival and quality of life of patients with low risk prostate cancer treated with high implant dose LDR prostate brachytherapy. 3nd Panhellenic Oncological-Imaging Congress. December 13-15, 2013. Mitera Hospital, Congress Center “N. Louros”, Maroussi, Athens, Greece.